Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Applying Results of Extended Genotyping to Management of Positive Cervicovaginal Human Papillomavirus Test Results: Enduring Guidelines

10 Jan 2025

Abstract excerpt

OBJECTIVE: The Enduring Consensus Cervical Cancer Screening and Management Guidelines Committee developed recommendations for the use of extended genotyping results in cervical cancer prevention programs. METHODS: Risks of cervical intraepithelial neoplasia grade 3 or worse were calculated using data obtained with the Onclarity HPV Assay from large cohorts. Management recommendations were based on clinical action...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cervical Cancer and HPV Research
Share to Endometrial and Cervical Cancer Treatments
Share to Head and Neck Cancer Studies

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 39791481
DOI: 10.1097/lgt.0000000000000865

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Applying Results of Extended Genotyping to Management of Positive Cervicovaginal Human Papillomavirus Test Results: Enduring GuidelinesPMID 39791481Read ↗

Clinical significance of extended high-risk human papillomavirus genotyping and viral load in cervical cancer and precancerous lesionsSemantic proximity Read ↗

A Study of Partial Human Papillomavirus Genotyping in Support of the 2019 ASCCP Risk-Based Management Consensus Guidelines.Semantic proximity Read ↗

Improving cervical screening risk stratification through extended human papillomavirus genotyping and age-specific data.Semantic proximity Read ↗

Risk stratification for cervical neoplasia using extended high-risk HPV genotyping in women with ASC-US cytology: A large retrospective study from China.Semantic proximity Read ↗

Accelerating Cervical Cancer Screening With Human Papillomavirus Genotyping.Semantic proximity Read ↗

The Clinical Utility of Extended High-Risk HPV Genotyping in Women With ASC-US Cytology.Semantic proximity Read ↗

Moving forward-the 2019 ASCCP Risk-Based Management Consensus Guidelines for Abnormal Cervical Cancer Screening Tests and Cancer Precursors and beyond: implications and suggestions for laboratories.Semantic proximity Read ↗

Risk of cervical high-grade squamous intraepithelial neoplasia in cytologic negative and persistently high-risk human papillomavirus positive patients according to genotypes: a retrospective single center analysis.Semantic proximity Read ↗

Diagnostic accuracy of extended HPV DNA genotyping and its application for risk-based cervical cancer screening strategy.Semantic proximity Read ↗

Molecular tests potentially improving HPV screening and genotyping for cervical cancer preventionSemantic proximity Read ↗

Extended Human Papillomavirus Genotyping to Predict Progression to High-Grade Cervical Precancer: A Prospective Cohort Study in the Southeastern United States.Semantic proximity Read ↗

Use of extended HR-HPV Genotyping in improving the Triage Strategy of 2019 ASCCP recommendations in Women with positive HR-HPV diagnosis and Simultaneous LSIL Cytology ResultsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.